123 related articles for article (PubMed ID: 38100919)
1. Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature.
Mulders MCF; Audhoe AS; Van Koetsveld PM; Feelders RA; Hofland LJ; de Herder WW; Kraaij R; Hofland J
Eur J Cancer; 2024 Jan; 197():113472. PubMed ID: 38100919
[TBL] [Abstract][Full Text] [Related]
2. Faecal microbiome and metabolic signatures in rectal neuroendocrine tumors.
Hu W; Chen ZM; Li XX; Lu L; Yang GH; Lei ZX; You LJ; Cui XB; Lu SC; Zhai ZY; Zeng ZY; Chen Y; Huang SL; Gong W
Theranostics; 2022; 12(5):2015-2027. PubMed ID: 35265196
[No Abstract] [Full Text] [Related]
3. Plasmatic and Urinary 5-Hydroxyindolacetic Acid Measurements in Patients With Midgut Neuroendocrine Tumors: A GTE Study.
de Mestier L; Savagner F; Brixi H; Do Cao C; Dominguez-Tinajero S; Roquin G; Goichot B; Hentic O; Dubreuil O; Hautefeuille V; Walter T; Cadiot G
J Clin Endocrinol Metab; 2021 Mar; 106(4):e1673-e1682. PubMed ID: 33382891
[TBL] [Abstract][Full Text] [Related]
4. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
[TBL] [Abstract][Full Text] [Related]
5. Echocardiography in functional midgut neuroendocrine tumors: When and how often.
Castillo JG; Naib T; Zacks JS; Adams DH
Rev Endocr Metab Disord; 2017 Dec; 18(4):411-421. PubMed ID: 29080935
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Threshold for Circulating Tumor Cells in Patients With Pancreatic and Midgut Neuroendocrine Tumors.
Mandair D; Khan MS; Lopes A; Furtado O'Mahony L; Ensell L; Lowe H; Hartley JA; Toumpanakis C; Caplin M; Meyer T
J Clin Endocrinol Metab; 2021 Mar; 106(3):872-882. PubMed ID: 33180939
[TBL] [Abstract][Full Text] [Related]
7. Mesenteric Fibrosis in Midgut Neuroendocrine Tumors: Functionality and Radiological Features.
Rodríguez Laval V; Pavel M; Steffen IG; Baur AD; Dilz LM; Fischer C; Detjen K; Prasad V; Pascher A; Geisel D; Denecke T
Neuroendocrinology; 2018; 106(2):139-147. PubMed ID: 28384635
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with midgut neuroendocrine tumors undergoing resective surgery.
Pozza A; Pauletti B; Scarpa M; Ruffolo C; Bassi N; Massani M
Int J Colorectal Dis; 2019 Nov; 34(11):1849-1856. PubMed ID: 31520198
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of bone metastases detected by
Deleval N; Pesque L; Dieudonné A; Viry F; Hentic O; Lebtahi R; Ruszniewski P; de Mestier L
Eur Radiol; 2021 Jun; 31(6):4166-4174. PubMed ID: 33247341
[TBL] [Abstract][Full Text] [Related]
10. Gene expression in midgut carcinoid tumors: potential targets for immunotherapy.
Vikman S; Essand M; Cunningham JL; de la Torre M; Oberg K; Tötterman TH; Giandomenico V
Acta Oncol; 2005; 44(1):32-40. PubMed ID: 15848904
[TBL] [Abstract][Full Text] [Related]
11. Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops.
Eriksson J; Norlén O; Ögren M; Garmo H; Ihre-Lundgren C; Hellman P
Scand J Surg; 2021 Mar; 110(1):44-50. PubMed ID: 31587594
[TBL] [Abstract][Full Text] [Related]
12. Population-based metagenomics analysis reveals altered gut microbiome in sarcopenia: data from the Xiangya Sarcopenia Study.
Wang Y; Zhang Y; Lane NE; Wu J; Yang T; Li J; He H; Wei J; Zeng C; Lei G
J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2340-2351. PubMed ID: 35851765
[TBL] [Abstract][Full Text] [Related]
13. Two cases of lung neuroendocrine carcinoma with carcinoid morphology.
Inafuku K; Yokose T; Ito H; Eriguchi D; Samejima J; Nagashima T; Nakayama H; Suzuki M; Yamada K; Masuda M
Diagn Pathol; 2019 Sep; 14(1):104. PubMed ID: 31511024
[TBL] [Abstract][Full Text] [Related]
14. Gastroenteropancreatic neuroendocrine (carcinoid) tumors in children.
Johnson PR
Semin Pediatr Surg; 2014 Apr; 23(2):91-5. PubMed ID: 24931354
[TBL] [Abstract][Full Text] [Related]
15. Midgut carcinoid patients display increased numbers of regulatory T cells in peripheral blood with infiltration into tumor tissue.
Vikman S; Sommaggio R; De La Torre M; Oberg K; Essand M; Giandomenico V; Loskog A; Totterman TH
Acta Oncol; 2009; 48(3):391-400. PubMed ID: 18855160
[TBL] [Abstract][Full Text] [Related]
16. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.
Kostiainen I; Karppinen N; Simonen P; Rosengård-Bärlund M; Lindén R; Tarkkanen M; Gordin D; Rapola J; Schalin-Jäntti C; Matikainen N
Endocrine; 2022 Jun; 77(1):177-187. PubMed ID: 35536452
[TBL] [Abstract][Full Text] [Related]
17. 131I-meta-iodobenzylguanidine in the management of metastatic midgut carcinoid tumors.
Sywak MS; Pasieka JL; McEwan A; Kline G; Rorstad O
World J Surg; 2004 Nov; 28(11):1157-62. PubMed ID: 15490060
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Gut Microbiome and Metabolite Characteristics in Patients with Slow Transit Constipation.
Tian H; Chen Q; Yang B; Qin H; Li N
Dig Dis Sci; 2021 Sep; 66(9):3026-3035. PubMed ID: 32767153
[TBL] [Abstract][Full Text] [Related]
19. Anesthetic Management of Gastrointestinal Carcinoid Tumors: A Case Report.
Wiederholt B; Gengler T; Bendure J
AANA J; 2022 Oct; 90(5):377-382. PubMed ID: 36173796
[TBL] [Abstract][Full Text] [Related]
20. Associations between Diet, the Gut Microbiome, and Short-Chain Fatty Acid Production among Older Caribbean Latino Adults.
Maldonado-Contreras A; Noel SE; Ward DV; Velez M; Mangano KM
J Acad Nutr Diet; 2020 Dec; 120(12):2047-2060.e6. PubMed ID: 32798072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
